AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
EXEMESTANE in Zimbabwe
3 products registered with MCAZ — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EXEMEX 25 TABLET, COATED; ORAL | 2023/9.5.2/6461 | INNOVATA PHARMACEUTICALS | active | 21 Aug 2028 |
| EQUISIN TABLET, COATED; ORAL | 2024/9.5.2/6554 | EQUITY PHARMACEUTICALS (PTY) LTD | active | 31 Dec 2027 |
| EXEDRAL TABLET, COATED; ORAL | 2019/9.5.2/5942 | REMEDICA LTD | active | 31 Dec 2027 |
EXEMESTANE — MCAZ Registration Details
MCAZ (Zimbabwe) has 3 registered products containing EXEMESTANE, of which 3 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track EXEMESTANE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.